# Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

> **NCT04868981** · PHASE1 · COMPLETED · sponsor: **Fujian Cosunter Pharmaceutical Co. Ltd** · enrollment: 30 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** GST-HG141 tablets
- **DRUG:** Matching Placebos for GST-HG141 tablets

## Key facts

- **NCT ID:** NCT04868981
- **Lead sponsor:** Fujian Cosunter Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-31
- **Primary completion:** 2022-02-23
- **Final completion:** 2022-03-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04868981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04868981, "Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04868981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*